Adenocarcinoma of the Esophagus Terminated Phase 1 / 2 Trials for Fluorouracil (DB00544)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00064259A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerTreatment